Compare OMF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMF | BIO |
|---|---|---|
| Founded | 1920 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.1B |
| IPO Year | 2013 | N/A |
| Metric | OMF | BIO |
|---|---|---|
| Price | $57.42 | $292.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $66.75 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 1.6M | 273.6K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.39% | N/A |
| EPS Growth | ★ 54.72 | N/A |
| EPS | ★ 6.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $68.08 | $2.59 |
| Revenue Next Year | $6.90 | $3.21 |
| P/E Ratio | ★ $8.68 | $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.45 | $211.43 |
| 52 Week High | $71.93 | $343.12 |
| Indicator | OMF | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 64.35 |
| Support Level | $55.80 | $256.85 |
| Resistance Level | $58.02 | $311.09 |
| Average True Range (ATR) | 1.37 | 7.57 |
| MACD | 0.73 | 2.28 |
| Stochastic Oscillator | 95.90 | 90.94 |
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.